Article
Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency.
Journal of inherited metabolic disease - 1 Feb 2008
Derks T G J, Boer T S, van Assen A, Bos T, Ruiter J, Waterham H R, Niezen-Koning K E, Wanders R J A, Rondeel J M M, Loeber J G, Ten Kate L P, Smit G P A, Reijngoud D-J
Abstract excerpt
The outcome was determined of population-wide neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency using tandem mass spectrometry (MS/MS) in The Netherlands, between October 2003 and September 2005. Prospective population-wide neonatal screening for MCAD deficiency was performed in the northern part of The Netherlands. In newborns with blood octanoylcarnitine (C(8:0)) concentrations > or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
